NovioSense Announces Positive Phase 2 Clinical Trial Results and the Commencement of a Second Follow Up Study
NovioSense has demonstrated the measurement of tear glucose in diabetic patients and the correlation to blood glucose with clinically relevant accuracy. The company announced the commencement of a second, 24-patient study, to validate the use of its